References
Bodor GS (2016). Biochemical Markers of Myocardial Damage. EJIFCC
27: 95-111.
Butler A, Hoffman P, Smibert P, Papalexi E, & Satija R (2018).
Integrating single-cell transcriptomic data across different conditions,
technologies, and species. Nat Biotechnol 36: 411-420.
Dong N, Cai J, Zhou Y, Liu J, & Li F (2020). End-stage Heart Failure
with COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV. JACC
Heart Fail.
Dong Y, Li X, Yu Y, Lv F, & Chen Y (2020). JAK/STAT signaling is
involved in IL-35-induced inhibition of hepatitis B virus
antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B.
Life Sci 252: 117663.
Doust JA, Pietrzak E, Dobson A, & Glasziou PP (2005). How well does
B-type natriuretic peptide predict death and cardiac events in patients
with heart failure: systematic review. Brit Med J 330: 625-627.
Fu Y, Cheng Y, & Wu Y (2020). Understanding SARS-CoV-2-Mediated
Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools.
Virol Sin.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. (2020).
Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J
Med 382: 1708-1720.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. (2020).
Cardiovascular Implications of Fatal Outcomes of Patients With
Coronavirus Disease 2019 (COVID-19). JAMA Cardiol.
Halushka PV, Goodwin AJ, & Halushka MK (2019). Opportunities for
microRNAs in the Crowded Field of Cardiovascular Biomarkers. Annu Rev
Pathol 14: 211-238.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (2020).
Clinical features of patients infected with 2019 novel coronavirus in
Wuhan, China. Lancet 395: 497-506.
Kawase M, Shirato K, van der Hoek L, Taguchi F, & Matsuyama S (2012).
Simultaneous treatment of human bronchial epithelial cells with serine
and cysteine protease inhibitors prevents severe acute respiratory
syndrome coronavirus entry. J Virol 86: 6537-6545.
Lee YJ, Lee J, Park YS, Lee SM, Yim JJ, Yoo CG, et al. (2013).
Predictors of cardiogenic and non-cardiogenic causes in cases with
bilateral chest infiltrates. Tuberc Respir Dis (Seoul) 74:15-22.
Li L, Wang L, Li H, Han X, Chen S, Yang B, et al. (2018).
Characterization of LncRNA expression profile and identification of
novel LncRNA biomarkers to diagnose coronary artery disease.
Atherosclerosis 275: 359-367.
Lippi G, Lavie CJ, & Sanchis-Gomar F (2020). Cardiac troponin I in
patients with coronavirus disease 2019 (COVID-19): Evidence from a
meta-analysis. Prog Cardiovasc Dis.
Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, et al. (2020).
Initial CT findings and temporal changes in patients with the novel
coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan,
China. Eur Radiol 30: 3306-3309.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. (2020).
Association of Cardiac Injury With Mortality in Hospitalized Patients
With COVID-19 in Wuhan, China. JAMA Cardiol.
Singhal T (2020). A Review of Coronavirus Disease-2019 (COVID-19).
Indian J Pediatr 87: 281-286.
South AM, Diz DI, & Chappell MC (2020). COVID-19, ACE2, and the
cardiovascular consequences. Am J Physiol Heart Circ Physiol
318: H1084-H1090.
Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, & Kantoff PW (2020).
TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?
Cancer Discov.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. (2020a).
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel
Coronavirus-Infected Pneumonia in Wuhan, China. JAMA.
Wang L, Yu P, Zhou B, Song J, Li Z, Zhang M, et al. (2020b).
Single-cell reconstruction of the adult human heart during heart failure
and recovery reveals the cellular landscape underlying cardiac function.
Nat Cell Biol 22: 108-119.
Zhang H, Penninger JM, Li Y, Zhong N, & Slutsky AS (2020).
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor:
molecular mechanisms and potential therapeutic target. Intensive Care
Med 46: 586-590.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. (2020). Risk
factors of critical & mortal COVID-19 cases: A systematic literature
review and meta-analysis. The Journal of infection.
Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R, Jr., Nunneley JW,
et al. (2015). Protease inhibitors targeting coronavirus and filovirus
entry. Antiviral Res 116: 76-84.
Zou X, Chen K, Zou J, Han P, Hao J, & Han Z (2020). Single-cell RNA-seq
data analysis on the receptor ACE2 expression reveals the potential risk
of different human organs vulnerable to 2019-nCoV infection. Front Med.